NCT05632042

Brief Summary

complaint of sexual dysfunction and metabolic syndrome are highly reported in men with psoriasis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 16, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 20, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2023

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

6 months

First QC Date

November 20, 2022

Last Update Submit

November 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • International Index of Erectile Function

    Arabic version of this 5-item questionnaire will used to assess erectile function/dysfunction

    It will be measured after 12-week intervention

Secondary Outcomes (8)

  • psoriasis area and severity index

    It will be measured after 12-week intervention

  • body mass index

    It will be measured after 12-week intervention

  • systolic blood pressure

    It will be measured after 12-week intervention

  • diastolic blood presure

    It will be measured after 12-week intervention

  • waist circumference

    It will be measured after 12-week intervention

  • +3 more secondary outcomes

Study Arms (2)

lifestyle-modification group

EXPERIMENTAL

erectile dysfunction (ED) psoriatic men with metabolic syndrome (group = 30 patients) will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)

Behavioral: lifestyle modification (exercise and control of diet)

control group

NO INTERVENTION

erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 30) that will receive no lifestyle changes/modifications.

Interventions

erectile dysfunction (ED) psoriatic men with metabolic syndrome that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)

lifestyle-modification group

Eligibility Criteria

Age35 Years - 45 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsbased on self-representation of gender identity
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • psoriatic married men with metabolic syndrome and erectile dysfunction

You may not qualify if:

  • patients with heart, respiratory, other autoimmune problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo Unoversity

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

PsoriasisMetabolic SyndromeErectile Dysfunction

Interventions

Exercise

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ali Ismail, lecturer

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ali Ismail, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University

Study Record Dates

First Submitted

November 20, 2022

First Posted

November 30, 2022

Study Start

October 16, 2022

Primary Completion

April 16, 2023

Study Completion

April 16, 2023

Last Updated

November 30, 2022

Record last verified: 2022-11

Locations